Aug 30, 2024
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts.
Show reference:
Blood Biomarkers to Detect Alzheimer Disease - Part 1
Aug 30, 2024
In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts.
Show reference:
Aug 29, 2024
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Calium discuss the risk of developing dementia among patients with MCI at three or five-year time points.
Show reference:
Aug 28, 2024
Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease.
Show reference:
https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496
Aug 27, 2024
Dr. Jeff Ratliff discusses an exciting study in the world of deep brain stimulation for Parkinson disease.
Show reference: